PsychDB
  • About
  1. You are here
  2. Home
  3. Psychopharmacology
  4. Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
  5. Valbenazine (Ingrezza)
Menu
Menu
  • Home
  • On-Call + Resources
  • Psychopharmacology
  • Teaching Files
  • Psychotherapy
  • Cognitive Testing
  • Neurology
  • Personality Disorders
Table of Contents
  • Valbenazine (Ingrezza)
    • Primer
    • Resources
  • Last edited on February 24, 2021

Valbenazine (Ingrezza)

Table of Contents
  • Valbenazine (Ingrezza)
    • Primer
    • Resources

Primer

Valbenazine (Trade name: Ingrezza), is used to treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor.

    • Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
    • Tetrabenazine (Nitoman/Xenazine)
    • Valbenazine (Ingrezza)

Resources

Contrarian Views
  • MadInAmerica: The Latest “Breakthrough Therapy”: Expensive New Drugs for Tardive Dyskinesia
Disclaimer: This website does not provide medical advice, nor is it a substitute for clinical judgment. See Disclaimer, Terms of Use, and Privacy Policy. Amazon Associate: PsychDB is an Amazon Associate and may earn from qualifying purchases from affiliate links on this website. 🇨🇦  Made in Canada.
Proudly hosted by Dreamhost